DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...
FVCBankcorp, Inc. (NASDAQ: FVCB) (the "Company") today reported net income of $5.6 million for the quarter ended December 31, 2025 compared to net income of $4.9 million for the quarter ended December ...
Q4 2025 Earnings Call January 20, 2026 1:00 PM ESTCompany ParticipantsSioban Hickie - Vice President of Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback